Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients
about
The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer.The Roles of Glycodelin in Cancer Development and Progression.Glycodelin expression in pregnant patients with cervical intraepithelial neoplasia: a case-control study.
P2860
Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients
description
im Juli 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2010
@uk
name
Glycodelin expression associat ...... BRCA1/2 breast cancer patients
@en
Glycodelin expression associat ...... BRCA1/2 breast cancer patients
@nl
type
label
Glycodelin expression associat ...... BRCA1/2 breast cancer patients
@en
Glycodelin expression associat ...... BRCA1/2 breast cancer patients
@nl
prefLabel
Glycodelin expression associat ...... BRCA1/2 breast cancer patients
@en
Glycodelin expression associat ...... BRCA1/2 breast cancer patients
@nl
P2093
P2860
P50
P1476
Glycodelin expression associat ...... BRCA1/2 breast cancer patients
@en
P2093
Kristiina Aittomäki
Laura C. Hautala
Päivi Heikkilä
Riitta Koistinen
P2860
P2888
P356
10.1007/S10549-010-1065-Y
P407
P577
2010-07-30T00:00:00Z